(Total Views: 486)
Posted On: 06/24/2025 5:57:41 PM
Post# of 154604
Slice n dice it:
* "The study builds on the Company’s prior research demonstrating the potential clinical benefit of leronlimab in patients with relapsed CRC, ...."
*"....and the Company’s ongoing clinical investigation efforts in CRC,...."
100% relates to the coming CRC poster & addtl survivor data to join mTNBC
The CRC survivors will be from the trial that included PD-L1 outcome measurement ---- will also have been ICI dosed, like Ladies of Leronlimab were
Like there's a current mTNBC follow-up verification,
this new CRC trial will be follow-up verification to the CRC poster of tommorrow....
That's my bet....
* "The study builds on the Company’s prior research demonstrating the potential clinical benefit of leronlimab in patients with relapsed CRC, ...."
*"....and the Company’s ongoing clinical investigation efforts in CRC,...."
100% relates to the coming CRC poster & addtl survivor data to join mTNBC
The CRC survivors will be from the trial that included PD-L1 outcome measurement ---- will also have been ICI dosed, like Ladies of Leronlimab were
Like there's a current mTNBC follow-up verification,
this new CRC trial will be follow-up verification to the CRC poster of tommorrow....
That's my bet....
(5)
(0)
